Pulmonary biofilm-based chronic infections and inhaled treatment strategies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pulmonary biofilm-based chronic infections and inhaled treatment strategies
Authors
Keywords
Infections, Pulmonary, Drug delivery, Biofilm, Inhalation, Antimicrobial agents, Liposome, Inhalation devices
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 604, Issue -, Pages 120768
Publisher
Elsevier BV
Online
2021-06-03
DOI
10.1016/j.ijpharm.2021.120768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhaled fixed-dose combination powders for the treatment of respiratory infections
- (2021) Ashlee D. Brunaugh et al. Expert Opinion on Drug Delivery
- Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis
- (2021) Poushali Chakraborty et al. Nature Communications
- Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus
- (2020) Grant Waterer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler
- (2020) Claudio Sorino et al. European Journal of Internal Medicine
- A novel, quorum sensor-infused liposomal drug delivery system suppresses Candida albicans biofilms
- (2020) H.M.H.N. Bandara et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children
- (2020) Karl Bass et al. AAPS PHARMSCITECH
- The Stabilizing Excipients in Dry State Therapeutic Phage Formulations
- (2020) Yajie Zhang et al. AAPS PHARMSCITECH
- Post-inhalation cough with therapeutic aerosols: Formulation considerations
- (2020) Sawittree Sahakijpijarn et al. ADVANCED DRUG DELIVERY REVIEWS
- Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
- (2020) Christie Mitri et al. Frontiers in Pharmacology
- Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
- (2019) Charles S Haworth et al. Lancet Respiratory Medicine
- Global, Regional, National, and Subnational Big Data to Inform Health Equity Research: Perspectives from the Global Burden of Disease Study 2017
- (2019) Ali H. Mokdad et al. ETHNICITY & DISEASE
- Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
- (2019) Matt Shirley DRUGS
- A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms
- (2019) Na Yang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Antibiotics versus biofilm: an emerging battleground in microbial communities
- (2019) Divakar Sharma et al. Antimicrobial Resistance and Infection Control
- Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy
- (2018) Purnima V. Gupta et al. AAPS PHARMSCITECH
- Near-Infrared Light-Activated Thermosensitive Liposomes as Efficient Agents for Photothermal and Antibiotic Synergistic Therapy of Bacterial Biofilm
- (2018) Yu Zhao et al. ACS Applied Materials & Interfaces
- Effective treatment of the Mycobacterium avium subsp hominissuis and Mycobacterium abscessus sp. infections in macrophages, biofilm and in mice using Liposomal ciprofloxacin
- (2018) James D. Blanchard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid
- (2018) Gillian Clary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
- (2018) Anthony De Soyza et al. EUROPEAN RESPIRATORY JOURNAL
- RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
- (2018) Timothy Aksamit et al. EUROPEAN RESPIRATORY JOURNAL
- PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro
- (2018) Tania F. Bahamondez-Canas et al. MOLECULAR PHARMACEUTICS
- Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection
- (2018) Ching-Yee Loo et al. PHARMACEUTICAL RESEARCH
- Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
- (2018) Jimin Zhang et al. Frontiers in Microbiology
- Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections
- (2018) Rachit Agarwal et al. Nature Biomedical Engineering
- A novel pH-responsive quaternary ammonium chitosan-liposome nanoparticles for periodontal treatment
- (2018) Fang Hu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections
- (2018) Zora Rukavina et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Isolation and characterization of a broad-spectrum phage of multiple drug resistant Salmonella and its therapeutic utility in mice
- (2018) Fang Tang et al. MICROBIAL PATHOGENESIS
- Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities
- (2017) Moayad Alhariri et al. International Journal of Nanomedicine
- Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin
- (2017) Sun Hee Moon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pseudomonas phage inhibition of Candida albicans
- (2017) Hasan Nazik et al. MICROBIOLOGY-SGM
- Pulmonary delivery of synergistic combination of fluoroquinolone antibiotic complemented with proteolytic enzyme: A novel antimicrobial and antibiofilm strategy
- (2017) Purnima V. Gupta et al. Nanomedicine-Nanotechnology Biology and Medicine
- Aminoglycoside interactions and impacts on the eukaryotic ribosome
- (2017) Irina Prokhorova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
- (2017) M. Fata Moradali et al. Frontiers in Cellular and Infection Microbiology
- Hot topics in reactive oxygen therapy: Antimicrobial and immunological mechanisms, safety and clinical applications
- (2017) Matthew Dryden et al. Journal of Global Antimicrobial Resistance
- Recent developments in the use of nanoparticles for treatment of biofilms
- (2017) Chendong Han et al. Nanotechnology Reviews
- Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy
- (2017) Marco Mantero et al. Therapeutic Advances in Respiratory Disease
- Bactericidal Effect of a Photoresponsive Carbon Monoxide-Releasing Nonwoven against Staphylococcus aureus Biofilms
- (2016) Mareike Klinger-Strobel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Glutathione-Disrupted Biofilms of Clinical Pseudomonas aeruginosa Strains Exhibit an Enhanced Antibiotic Effect and a Novel Biofilm Transcriptome
- (2016) William Klare et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liposome containing cinnamon oil with antibacterial activity against methicillin-resistantStaphylococcus aureusbiofilm
- (2016) Haiying Cui et al. BIOFOULING
- The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms
- (2016) Wei Jia et al. BMC MICROBIOLOGY
- Host-pathogen interactions of nontypeableHaemophilus influenzae: from commensal to pathogen
- (2016) Benjamin Luke Duell et al. FEBS LETTERS
- Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study
- (2016) Caroline Deppisch et al. INFECTION
- Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection
- (2016) J. Stuart Elborn et al. Journal of Cystic Fibrosis
- Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro
- (2016) H. M. H. N. Bandara et al. MOLECULAR PHARMACEUTICS
- A multi-centre clinical evaluation of reactive oxygen topical wound gel in 114 wounds
- (2016) M. Dryden et al. Journal of Wound Care
- Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
- (2016) Sami Abdellatif et al. Annals of Intensive Care
- The 1.1 Å resolution structure of a periplasmic phosphate-binding protein fromStenotrophomonas maltophilia: a crystallization contaminant identified by molecular replacement using the entire Protein Data Bank
- (2016) Ronan Keegan et al. Acta Crystallographica Section D-Structural Biology
- pH-Activated Nanoparticles for Controlled Topical Delivery of Farnesol To Disrupt Oral Biofilm Virulence
- (2015) Benjamin Horev et al. ACS Nano
- Biofilms of Pathogenic Nontuberculous Mycobacteria Targeted by New Therapeutic Approaches
- (2015) Thet Tun Aung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa
- (2015) Mike Wilton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nitric Oxide Regulation of Bacterial Biofilms
- (2015) Dhruv P. Arora et al. BIOCHEMISTRY
- Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs
- (2015) Peter Jorth et al. Cell Host & Microbe
- Mechanism for glutathione-mediated protection against the Pseudomonas aeruginosa redox toxin, pyocyanin
- (2015) Michael Muller et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Analysis of the Aspergillus fumigatus Biofilm Extracellular Matrix by Solid-State Nuclear Magnetic Resonance Spectroscopy
- (2015) Courtney Reichhardt et al. EUKARYOTIC CELL
- Chronic pulmonary disease withMycobacterium abscessuscomplex is a biofilm infection
- (2015) Tavs Qvist et al. EUROPEAN RESPIRATORY JOURNAL
- Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation
- (2015) Ibrahim Elsayed et al. Expert Opinion on Drug Delivery
- Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients
- (2015) Gregory S. Sawicki et al. Journal of Cystic Fibrosis
- Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study
- (2015) H.A.W.M. Tiddens et al. Journal of Cystic Fibrosis
- Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response
- (2015) Morten Rybtke et al. JOURNAL OF MOLECULAR BIOLOGY
- Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms
- (2015) Ju Du et al. MOLECULAR PHARMACEUTICS
- Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus
- (2015) Yansha Meng et al. PHARMACEUTICAL RESEARCH
- Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation
- (2015) Theerthankar Das et al. Scientific Reports
- Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms
- (2015) Marlise I. Klein et al. Frontiers in Cellular and Infection Microbiology
- Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods
- (2015) Kenichiro Shimizu et al. International Journal of Chronic Obstructive Pulmonary Disease
- Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics
- (2015) Sasha J. Rose et al. PLoS One
- Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation
- (2015) Katherine E. Price et al. PLoS One
- Advanced endotracheal tube biofilm stage, not duration of intubation, is related to pneumonia
- (2015) Alison Wilson et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- EnhancedIn VitroFormation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products
- (2014) Silvia M. Caceres et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments
- (2014) Marwan Abdallah et al. ARCHIVES OF MICROBIOLOGY
- Strategies for Antimicrobial Drug Delivery to Biofilm
- (2014) Claire Martin et al. CURRENT PHARMACEUTICAL DESIGN
- Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistantStaphylococcus aureusinfection
- (2014) Yanhong Li et al. DRUG DELIVERY
- Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells
- (2014) Anna C. Zemke et al. FREE RADICAL BIOLOGY AND MEDICINE
- Peroxiredoxin-Glutaredoxin and Catalase Promote Resistance of Nontypeable Haemophilus influenzae 86-028NP to Oxidants and Survival within Neutrophil Extracellular Traps
- (2014) Richard A. Juneau et al. INFECTION AND IMMUNITY
- Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells
- (2014) S. Moreau-Marquis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role for the A Domain of Unprocessed Accumulation-Associated Protein (Aap) in the Attachment Phase of the Staphylococcus epidermidis Biofilm Phenotype
- (2014) B. P. Conlon et al. JOURNAL OF BACTERIOLOGY
- Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms
- (2014) Katrien Forier et al. JOURNAL OF CONTROLLED RELEASE
- Endotracheal tube biofilm and ventilator-associated pneumonia with mechanical ventilation
- (2014) Paula Regina De Souza et al. MICROSCOPY RESEARCH AND TECHNIQUE
- Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis
- (2014) Henryk Mazurek et al. PEDIATRIC PULMONOLOGY
- Description and Microbiology of Endotracheal Tube Biofilm in Mechanically Ventilated Subjects
- (2014) P.-E. Danin et al. Respiratory Care
- Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
- (2014) Alan F Barker et al. Lancet Respiratory Medicine
- The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeableHemophilus influenzaebiofilms to treatment with ampicillin and ciprofloxacin
- (2014) Rosalia Cavaliere et al. MicrobiologyOpen
- Inhalation Treatment with Glutathione in Patients with Cystic Fibrosis. A Randomized Clinical Trial
- (2013) Matthias Griese et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Identification of Five Structurally Unrelated Quorum-Sensing Inhibitors of Pseudomonas aeruginosa from a Natural-Derivative Database
- (2013) Sean Yang-Yi Tan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Bacteriocins on Methicillin-Resistant Staphylococcus aureus Biofilm
- (2013) Ken-ichi Okuda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dormancy Is Not Necessary or Sufficient for Bacterial Persistence
- (2013) Mehmet A. Orman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liposomal Amphotericin B Displays Rapid Dose-Dependent Activity against Candida albicans Biofilms
- (2013) Gordon Ramage et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors
- (2013) Mai Alhajlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development
- (2013) Karthik Sambanthamoorthy et al. BIOFOULING
- Phase 3 Randomized Study of the Efficacy and Safety of Inhaled Dry Powder Mannitol for the Symptomatic Treatment of Non-Cystic Fibrosis Bronchiectasis
- (2013) Diana Bilton et al. CHEST
- Extracellular DNA Release Acts as an Antifungal Resistance Mechanism in Mature Aspergillus fumigatus Biofilms
- (2013) Ranjith Rajendran et al. EUKARYOTIC CELL
- Synergistic effect of doxycycline and fluconazole againstCandida albicansbiofilms and the impact of calcium channel blockers
- (2013) Yuan Gao et al. FEMS YEAST RESEARCH
- Investigation of dry powder aerosolization mechanisms in different channel designs
- (2013) Lan Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A randomized controlled trial of inhaled l-Arginine in patients with cystic fibrosis
- (2013) H. Grasemann et al. Journal of Cystic Fibrosis
- Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
- (2013) Valerie Waters et al. Journal of Cystic Fibrosis
- Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin
- (2013) Anne-Sophie Messiaen et al. Journal of Cystic Fibrosis
- Pyocyanin Facilitates Extracellular DNA Binding to Pseudomonas aeruginosa Influencing Cell Surface Properties and Aggregation
- (2013) Theerthankar Das et al. PLoS One
- Structural Stability of Burkholderia cenocepacia Biofilms Is Reliant on eDNA Structure and Presence of a Bacterial Nucleic Acid Binding Protein
- (2013) Laura A. Novotny et al. PLoS One
- Transport of Nanoparticles and Tobramycin-loaded Liposomes in Burkholderia cepacia Complex Biofilms
- (2013) Anne-Sophie Messiaen et al. PLoS One
- Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms
- (2013) Nicolas Barraud et al. PLoS One
- Two quorum sensing systems control biofilm formation and virulence in members of theBurkholderia cepaciacomplex
- (2013) Angela Suppiger et al. Virulence
- Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis
- (2013) Julie Ann Justo et al. Therapeutic Advances in Respiratory Disease
- Characterization of extracellular polymeric matrix, and treatment ofFusobacterium nucleatumandPorphyromonas gingivalisbiofilms with DNase I and proteinase K
- (2013) Marwan Mansoor Ali Mohammed et al. Journal of Oral Microbiology
- Interaction of the Echinocandin Caspofungin with Amphotericin B or Voriconazole against Aspergillus BiofilmsIn Vitro
- (2012) Weixia Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide
- (2012) César de la Fuente-Núñez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments
- (2012) C. Nagant et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin Enhances the Active Transport of Tobramycin in Pseudomonas aeruginosa
- (2012) David L. MacLeod et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroInteraction between Alginate Lyase and Amphotericin B against Aspergillus fumigatus Biofilm Determined by Different Methods
- (2012) Francesca Bugli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoPharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
- (2012) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones
- (2012) Gilles Brackman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New horizons for host defense peptides and lantibiotics
- (2012) Michael John Dawson et al. CURRENT OPINION IN PHARMACOLOGY
- New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa
- (2012) Thomas Hofmann CURRENT PHARMACEUTICAL DESIGN
- Mannitol Dry Powder for Inhalation
- (2012) Celeste B. Burness et al. DRUGS
- Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
- (2012) Robert Wilson et al. EUROPEAN RESPIRATORY JOURNAL
- Inhaled colistin for lower respiratory tract infections
- (2012) Sabina Antonela Antoniu et al. Expert Opinion on Drug Delivery
- Biofilm-specific antibiotic resistance
- (2012) Thien-Fah Mah Future Microbiology
- Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity
- (2012) Mélanie Fauvel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Biological Roles of Nontypeable Haemophilus influenzae Type IV Pilus Proteins Encoded by the pil and com Operons
- (2012) M. D. Carruthers et al. JOURNAL OF BACTERIOLOGY
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- (2012) Gerd Döring et al. Journal of Cystic Fibrosis
- Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
- (2012) Baroukh M. Assael et al. Journal of Cystic Fibrosis
- Proteus mirabilis urinary tract infection and bacteremia: Risk factors, clinical presentation, and outcomes
- (2012) Chi-Yu Chen et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation
- (2012) Chen Zhu et al. JOURNAL OF SURGICAL RESEARCH
- In vivomolecular microimaging of pulmonary aspergillosis
- (2012) Helene Morisse et al. MEDICAL MYCOLOGY
- Cathelicidins: family of antimicrobial peptides. A review
- (2012) Ewa M. Kościuczuk et al. MOLECULAR BIOLOGY REPORTS
- sarAnegatively regulatesStaphylococcus epidermidisbiofilm formation by modulating expression of 1 MDa extracellular matrix binding protein and autolysis-dependent release of eDNA
- (2012) Martin Christner et al. MOLECULAR MICROBIOLOGY
- Bacteriocins — a viable alternative to antibiotics?
- (2012) Paul D. Cotter et al. NATURE REVIEWS MICROBIOLOGY
- The Carbon Monoxide Releasing Molecule CORM-2 Attenuates Pseudomonas aeruginosa Biofilm Formation
- (2012) Thomas S. Murray et al. PLoS One
- Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
- (2012) Antje Schuster et al. THORAX
- Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
- (2012) Ravikumar B Shinde et al. Annals of Clinical Microbiology and Antimicrobials
- The Promise of Bacteriophage Therapy for Burkholderia cepacia Complex Respiratory Infections
- (2012) Diana D. Semler et al. Frontiers in Cellular and Infection Microbiology
- Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa
- (2011) David E. Geller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused byPseudomonas aeruginosa
- (2011) Qin Lu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection
- (2011) Bruce C. Trapnell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Azithromycin Inhibits Expression of the GacA-Dependent Small RNAs RsmY and RsmZ in Pseudomonas aeruginosa
- (2011) Isabel Pérez-Martínez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms
- (2011) Rinki Kapoor et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of the Poly-β-1,6-N-Acetylglucosamine Polysaccharide Component of Burkholderia Biofilms
- (2011) Nandadeva Yakandawala et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal LectureThis article is based on a presentation by Dr. Christopher Sibley at the 60th Annual Meeting of the Canadian Society of Microbiologists in Hamilton, Ontario, on 15 June 2010. Dr. Sibley was the recipient of the 2010 Cangene Gold Medal as the Canadian Graduate Student Microbiologist of the Year, an annual award sponsored by Cangene Corporation intended to recognize excellence in graduate research.
- (2011) Christopher D. Sibley et al. CANADIAN JOURNAL OF MICROBIOLOGY
- A novel highly charged exopolysaccharide produced by two strains of Stenotrophomonas maltophilia recovered from patients with cystic fibrosis
- (2011) Paola Cescutti et al. CARBOHYDRATE RESEARCH
- Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization
- (2011) Meenu Mishra et al. CELLULAR MICROBIOLOGY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa
- (2011) Helga Mikkelsen et al. ENVIRONMENTAL MICROBIOLOGY
- BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia
- (2011) Michael S. Niederman et al. INTENSIVE CARE MEDICINE
- Haemophilus influenzae in children with cystic fibrosis: Antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation
- (2011) Rita Cardines et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
- (2011) Seong-Cheol Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci
- (2011) Jeffrey B Kaplan et al. JOURNAL OF ANTIBIOTICS
- Effect of a low concentration of a cationic steroid antibiotic (CSA-13) on the formation of a biofilm by Pseudomonas aeruginosa
- (2011) C. Nagant et al. JOURNAL OF APPLIED MICROBIOLOGY
- Review: Staphylococcus aureus and MRSA in cystic fibrosis
- (2011) Christopher H. Goss et al. Journal of Cystic Fibrosis
- Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
- (2011) C.E. Wainwright et al. Journal of Cystic Fibrosis
- Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy
- (2011) Elizabeth M. Ryan et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection
- (2011) Dissaya Pornpattananangkul et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Aspergillus fumigatusbiofilms in the clinical setting
- (2011) Frank-Michael C. Müller et al. MEDICAL MYCOLOGY
- Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms
- (2011) Margarida Martins et al. MYCOSES
- Metabolite-enabled eradication of bacterial persisters by aminoglycosides
- (2011) Kyle R. Allison et al. NATURE
- Outpatient Treatment ofPseudomonas aeruginosaBronchial Colonization with Long-term Inhaled Colistin, Tobramycin, or Both in Adults without Cystic Fibrosis
- (2011) David Berlana et al. PHARMACOTHERAPY
- Molecular Analysis of Microbial Communities in Endotracheal Tube Biofilms
- (2011) Scott Cairns et al. PLoS One
- A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites
- (2011) Xuan Xiao et al. PLoS One
- Nuclease Modulates Biofilm Formation in Community-Associated Methicillin-Resistant Staphylococcus aureus
- (2011) Megan R. Kiedrowski et al. PLoS One
- Pseudomonas aeruginosaand Mortality after Hospital Admission for Chronic Obstructive Pulmonary Disease
- (2011) Pedro Almagro et al. RESPIRATION
- A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
- (2010) Maeve P. Murray et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sodium Nitrite-Mediated Killing of the Major Cystic Fibrosis Pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under Anaerobic Planktonic and Biofilm Conditions
- (2010) T. A. Major et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantifying Diffusion in a Biofilm ofStreptococcus mutans
- (2010) Zeshi Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Trp- and Arg-Containing Antimicrobial-Peptide Structure on Inhibition of Escherichia coli Planktonic Growth and Biofilm Formation
- (2010) S. Hou et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Diffusion Measurements inside Biofilms by Image-Based Fluorescence Recovery after Photobleaching (FRAP) Analysis with a Commercial Confocal Laser Scanning Microscope
- (2010) F. Waharte et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients
- (2010) Arianna Pompilio et al. BMC MICROBIOLOGY
- The immune system vs.Pseudomonas aeruginosabiofilms
- (2010) Peter Østrup Jensen et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation
- (2010) Eilidh Mowat et al. FEMS MICROBIOLOGY LETTERS
- The I-neb Adaptive Aerosol Delivery System Enhances Delivery of α1-Antitrypsin with Controlled Inhalation
- (2010) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes
- (2010) M. Alipour et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of BiofilmPseudomonas aeruginosa
- (2010) Gloria Herrmann et al. JOURNAL OF INFECTIOUS DISEASES
- The therapeutic potential of carbon monoxide
- (2010) Roberto Motterlini et al. NATURE REVIEWS DRUG DISCOVERY
- Bacteriophage resistance mechanisms
- (2010) Simon J. Labrie et al. NATURE REVIEWS MICROBIOLOGY
- The biofilm matrix
- (2010) Hans-Curt Flemming et al. NATURE REVIEWS MICROBIOLOGY
- Ventilator-associated Pneumonia or Endotracheal Tube-associated Pneumonia?
- (2009) Ioannis A. Pneumatikos et al. ANESTHESIOLOGY
- In Vitro Activity of Gallium Maltolate against Staphylococci in Logarithmic, Stationary, and Biofilm Growth Phases: Comparison of Conventional and Calorimetric Susceptibility Testing Methods
- (2009) D. Baldoni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial dendrimer active against Escherichia coli biofilms
- (2009) Shuyu Hou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- In vivobiofilm composition ofAspergillus fumigatus
- (2009) Céline Loussert et al. CELLULAR MICROBIOLOGY
- Increases in Endotracheal Tube Resistance Are Unpredictable Relative to Duration of Intubation
- (2009) Alison M. Wilson et al. CHEST
- Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection
- (2009) Alexandra L. Quittner et al. CHEST
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
- (2009) George Z. Retsch-Bogart et al. CHEST
- Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
- (2009) I.P. Korbila et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin in the 21st century
- (2009) Roger L Nation et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis
- (2009) L. Dales et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Recent advances in liposomal dry powder formulations: preparation and evaluation
- (2009) Ambikanandan Misra et al. Expert Opinion on Drug Delivery
- In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms
- (2009) Marisa H. Miceli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bismuth–thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa
- (2009) Majed Halwani et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Liposomes as delivery systems for antibiotics
- (2009) Zuzanna Drulis-Kawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa
- (2009) M. Alipour et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
- (2009) D. L. MacLeod et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model
- (2009) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nitric Oxide Signaling in Pseudomonas aeruginosa Biofilms Mediates Phosphodiesterase Activity, Decreased Cyclic Di-GMP Levels, and Enhanced Dispersal
- (2009) N. Barraud et al. JOURNAL OF BACTERIOLOGY
- Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France
- (2009) A.-L. Roux et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Colistin sulfate/tobramycin combination is superior for killing biofilm P. aeruginosa than monotherapy in vitro
- (2009) G. Herrmann et al. Journal of Cystic Fibrosis
- Intercellular adhesion and biocide resistance in nontypeable Haemophilus influenzae biofilms
- (2009) Era A. Izano et al. MICROBIAL PATHOGENESIS
- Bugs, Biofilms, and Resistance in Cystic Fibrosis
- (2009) Jane C Davies Respiratory Care
- Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms
- (2009) Nicolas Barraud et al. Microbial Biotechnology
- Biofilm Matrix Regulation by Candida albicans Zap1
- (2009) Clarissa J. Nobile et al. PLOS BIOLOGY
- Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial Inflammation
- (2008) Roberto Dal Negro et al. ADVANCES IN THERAPY
- Pseudomonas aeruginosain Chronic Obstructive Pulmonary Disease
- (2008) Timothy F. Murphy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis
- (2008) Karen S. McCoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Pathology of Chronic Obstructive Pulmonary Disease
- (2008) James C. Hogg et al. Annual Review of Pathology-Mechanisms of Disease
- Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms
- (2008) P. Uppuluri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of DNase and Antibiotics on Biofilm Characteristics
- (2008) G. V. Tetz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates
- (2008) Luanne Hall-Stoodley et al. BMC MICROBIOLOGY
- Colistin and Polymyxin B in Critical Care
- (2008) Argyris Michalopoulos et al. CRITICAL CARE CLINICS
- Mechanism and Inhibition of LpxC: An Essential Zinc-Dependent Deacetylase of Bacterial Lipid A Synthesis
- (2008) Pei Zhou et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Quorum sensing inPseudomonas aeruginosabiofilms
- (2008) T. R. de Kievit ENVIRONMENTAL MICROBIOLOGY
- Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
- (2008) J. Overhage et al. INFECTION AND IMMUNITY
- Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model
- (2008) Marie Tré-Hardy et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis
- (2008) Bruce K. Rubin Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium
- (2008) E. Peeters et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa
- (2008) M. Halwani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation
- (2008) A. Molina et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
- (2008) P. Meers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vascular System: Role of Nitric Oxide in Cardiovascular Diseases
- (2008) Ka Bian et al. Journal of Clinical Hypertension
- Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
- (2008) Volker Teichgräber et al. NATURE MEDICINE
- Biofilm formation of the pathogens of fatal bacterial granuloma after trauma: Potential mechanism underlying the failure of traditional antibiotic treatments
- (2008) Xianlong Qi et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria
- (2007) Tatsuichiro Shima et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started